NASDAQ
Orchard Therapeutics plc (ORTX) has a free cash flow growth of 13.61% as of Friday, May 29, 2026. This represents a 179.04% increase compared to its 12-month average of -17.22%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.